Mydriasert (phenylephrine + tropicamide) is a combination of mydriatic agents with a novel method of delivery, indicated for use before surgery or for diagnostic purposes when monotherapy is insufficient. The insert is placed into the conjunctival sac of the affected eye by an appropriately trained healthcare professional.
Compared with eye drops, the insert takes slightly longer to produce mydriasis; however, less nurse intervention may be required and eyesight recovery seems to be more rapid. The insert must be removed 30 minutes after achieving sufficient mydriasis and within 2 hours of insertion.
Further Information: Spectrum Thea Pharma